https://orcid.org/0000-0003-2947-7825
References
- Asou H, Matsui H, Ozaki Y, et al. Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome. Biochem Biophys Res Commun. 2009;383(2):245–251. doi: 10.1016/j.bbrc.2009.04.004
- Narumi S, Amano N, Ishii T, et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. Nat Genet. 2016;48(7):792–797. doi: 10.1038/ng.3569
- Chen DH, Below JE, Shimamura A, et al. Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L. Am J Human Genet. 2016;98(6):1146–1158. doi: 10.1016/j.ajhg.2016.04.009
- Ahmed IA, Farooqi MS, vander Lugt MT, et al. Outcomes of hematopoietic cell transplantation in patients with germline SAMD9/SAMD9L mutations. Biol Blood Marrow Transplant. 2019;25(11):2186–2196. doi: 10.1016/j.bbmt.2019.07.007
- Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424. doi: 10.1038/gim.2015.30
- Wickramasinghe W, Dissanayake R, Raj R, et al. The first report of allogeneic haematopoietic stem cell transplantations for bone marrow failure performed in Sri Lanka. Br.J.Haematol.2021;194:e56–e58. doi: 10.1111/bjh.17474
- Sahoo SS, Pastor VB, Goodings C, et al. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Nat Med. 2021;27(10):1806–1817. doi: 10.1038/s41591-021-01511-6
- Thomas ME, Abdelhamed S, Hiltenbrand R, et al. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells. Leukemia. 2021;35(11):3232–3244. doi: 10.1038/s41375-021-01212-6
- Inaba T, Honda H, Matsui H. Blood (2018) 131 (26): 2891–2898. https://doi.org/10.1182/blood-2017-12-822262
- Young NS. Aplastic anemia. Longo DL, editor. N Engl J Med. 2018;379(17):1643–1656. doi: 10.1056/NEJMra1413485
- Muramatsu H, Okuno Y, Yoshida K, et al. Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes. Genet Med. 2017;19(7):796–802. doi: 10.1038/gim.2016.197
- Pallavelangini S, Senguttuvan G, Bhatia P, et al. A well-curated cost-effective next-generation sequencing panel identifies a diverse landscape of pathogenic and novel germline variants in a bone marrow failure cohort in a resource-constraint setting. J Mol Diagn. 2023;25(10):748–757. doi: 10.1016/j.jmoldx.2023.06.009
- Zhang MY, Keel SB, Walsh T, et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica. 2015;100(1):42–48. doi: 10.3324/haematol.2014.113456